Literature DB >> 7602540

Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression.

A Wernig1, A Irintchev, G Lange.   

Abstract

1. The goals of this study were to evaluate the immunogenicity of myogenic cells (MCs) (1) immediately after implantation into regenerating muscles, and (2) following their maturation under initial immunosuppression. Implanted mouse soleus muscles were evaluated by isometric tension recordings in vitro followed by histological investigations on frozen sections. 2. Implantation of non-histocompatible myoblasts into cryodamaged soleus muscles of CBA/J mice induced immune rejection which caused large and permanent deficits in muscle force: 4-42 weeks postimplantation maximal tetanic tension was 50-60% that of intact or regenerated cryodamaged control muscles without tendency for recovery or histological signs of muscle regeneration. Specific tension (force per unit muscle weight) was also significantly reduced. 3. On frozen sections, only 62 +/- 12% of the total area was desmin-positive, that is, occupied by muscle fibres, versus 90 +/- 4% in regenerated and 92 +/- 3% in intact muscles. Also, the total number of muscle fibre profiles was significantly reduced. 4. Under immune suppression with cyclosporin A (CsA), large muscles developed within 4 weeks. Following CsA withdrawal, muscle weight and force, in addition to desmin-positive areas on cross-sections, gradually declined over several months despite continual regeneration, indicating retarded immune rejection. 5. Initial application of CsA for 8 weeks after implantation, instead of 4 weeks, did not result in better survival of the implants, nor did a higher initial dose of CsA (100 instead of 50 mg kg-1 day-1). Prolonged continuous application of a reduced dose (25 mg kg-1 day-1) did not prevent muscle wasting but caused an additional delay. 6. It is concluded that histoincompatible myoblasts are highly immunogenic and that immune rejection causes large and permanent muscle deficits indicating elimination of host muscle tissue. Initial transient immunosuppression protects the incompatible cells, but after withdrawal, prolonged immune rejection and retarded muscle wasting occur.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7602540      PMCID: PMC1157910          DOI: 10.1113/jphysiol.1995.sp020681

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  36 in total

1.  Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions.

Authors:  J Huard; R Roy; J P Bouchard; F Malouin; C L Richards; J P Tremblay
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Tumor necrosis factor induces skeletal muscle protein breakdown in rats.

Authors:  M N Goodman
Journal:  Am J Physiol       Date:  1991-05

3.  Myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy.

Authors:  J Huard; J P Bouchard; R Roy; C Labrecque; G Dansereau; B Lemieux; J P Tremblay
Journal:  Clin Sci (Lond)       Date:  1991-08       Impact factor: 6.124

4.  Allografts of muscle precursor cells persist in the non-tolerized host.

Authors:  D J Watt; J E Morgan; T A Partridge
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

5.  Reinnervation and recovery of mouse soleus muscle after long-term denervation.

Authors:  A Irintchev; A Draguhn; A Wernig
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

6.  Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.

Authors:  E Gussoni; G K Pavlath; A M Lanctot; K R Sharma; R G Miller; L Steinman; H M Blau
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

7.  Formation of new muscle fibres and tumours after injection of cultured myogenic cells.

Authors:  A Wernig; A Irintchev; A Härtling; G Stephan; K Zimmermann; A Starzinski-Powitz
Journal:  J Neurocytol       Date:  1991-12

8.  Differential expression of tenascin after denervation, damage or paralysis of mouse soleus muscle.

Authors:  A Irintchev; T F Salvini; A Faissner; A Wernig
Journal:  J Neurocytol       Date:  1993-11

9.  Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible.

Authors:  R Roy; J P Tremblay; J Huard; C Richards; F Malouin; J P Bouchard
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

10.  Myoblast transfer in Duchenne muscular dystrophy.

Authors:  G Karpati; D Ajdukovic; D Arnold; R B Gledhill; R Guttmann; P Holland; P A Koch; E Shoubridge; D Spence; M Vanasse
Journal:  Ann Neurol       Date:  1993-07       Impact factor: 10.422

View more
  4 in total

1.  NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy.

Authors:  Raquel Gómez-Sintes; José J Lucas
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

2.  Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles.

Authors:  A Wernig; M Zweyer; A Irintchev
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

3.  Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells.

Authors:  Daniel Skuk; Martin Paradis; Marlyne Goulet; Pierre Chapdelaine; David M Rothstein; Jacques P Tremblay
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

4.  Leucine supplementation accelerates connective tissue repair of injured tibialis anterior muscle.

Authors:  Marcelo G Pereira; Meiricris T Silva; Eduardo O C Carlassara; Dawit A Gonçalves; Paulo A Abrahamsohn; Isis C Kettelhut; Anselmo S Moriscot; Marcelo S Aoki; Elen H Miyabara
Journal:  Nutrients       Date:  2014-09-29       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.